These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

302 related articles for article (PubMed ID: 34358645)

  • 21. Imaging Mass Spectrometry Reveals Acyl-Chain- and Region-Specific Sphingolipid Metabolism in the Kidneys of Sphingomyelin Synthase 2-Deficient Mice.
    Sugimoto M; Wakabayashi M; Shimizu Y; Yoshioka T; Higashino K; Numata Y; Okuda T; Zhao S; Sakai S; Igarashi Y; Kuge Y
    PLoS One; 2016; 11(3):e0152191. PubMed ID: 27010944
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Adult ceramide synthase 2 (CERS2)-deficient mice exhibit myelin sheath defects, cerebellar degeneration, and hepatocarcinomas.
    Imgrund S; Hartmann D; Farwanah H; Eckhardt M; Sandhoff R; Degen J; Gieselmann V; Sandhoff K; Willecke K
    J Biol Chem; 2009 Nov; 284(48):33549-60. PubMed ID: 19801672
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Regulation of glucose homeostasis and insulin action by ceramide acyl-chain length: A beneficial role for very long-chain sphingolipid species.
    Montgomery MK; Brown SH; Lim XY; Fiveash CE; Osborne B; Bentley NL; Braude JP; Mitchell TW; Coster AC; Don AS; Cooney GJ; Schmitz-Peiffer C; Turner N
    Biochim Biophys Acta; 2016 Nov; 1861(11):1828-1839. PubMed ID: 27591968
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Ablation of ceramide synthase 2 causes chronic oxidative stress due to disruption of the mitochondrial respiratory chain.
    Zigdon H; Kogot-Levin A; Park JW; Goldschmidt R; Kelly S; Merrill AH; Scherz A; Pewzner-Jung Y; Saada A; Futerman AH
    J Biol Chem; 2013 Feb; 288(7):4947-56. PubMed ID: 23283968
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Defective ceramide synthases in mice cause reduced amplitudes in electroretinograms and altered sphingolipid composition in retina and cornea.
    Brüggen B; Kremser C; Bickert A; Ebel P; Vom Dorp K; Schultz K; Dörmann P; Willecke K; Dedek K
    Eur J Neurosci; 2016 Jul; 44(1):1700-13. PubMed ID: 27086873
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Hepatocyte ELOVL Fatty Acid Elongase 6 Determines Ceramide Acyl-Chain Length and Hepatic Insulin Sensitivity in Mice.
    Matsuzaka T; Kuba M; Koyasu S; Yamamoto Y; Motomura K; Arulmozhiraja S; Ohno H; Sharma R; Shimura T; Okajima Y; Han SI; Aita Y; Mizunoe Y; Osaki Y; Iwasaki H; Yatoh S; Suzuki H; Sone H; Takeuchi Y; Yahagi N; Miyamoto T; Sekiya M; Nakagawa Y; Ema M; Takahashi S; Tokiwa H; Shimano H
    Hepatology; 2020 May; 71(5):1609-1625. PubMed ID: 31529722
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Direct and maternal n-3 long-chain polyunsaturated fatty acid supplementation improved triglyceridemia and glycemia through the regulation of hepatic and muscle sphingolipid synthesis in offspring hamsters fed a high-fat diet.
    Kasbi-Chadli F; Ferchaud-Roucher V; Krempf M; Ouguerram K
    Eur J Nutr; 2016 Mar; 55(2):589-599. PubMed ID: 25787885
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Hepatic triglyceride accumulation via endoplasmic reticulum stress-induced SREBP-1 activation is regulated by ceramide synthases.
    Kim YR; Lee EJ; Shin KO; Kim MH; Pewzner-Jung Y; Lee YM; Park JW; Futerman AH; Park WJ
    Exp Mol Med; 2019 Nov; 51(11):1-16. PubMed ID: 31676768
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Targeted sphingolipid analysis in chickens suggests different mechanisms of fumonisin toxicity in kidney, lung, and brain.
    Guerre P; Matard-Mann M; Nyvall Collén P
    Food Chem Toxicol; 2022 Dec; 170():113467. PubMed ID: 36241089
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Lack of ceramide synthase 5 protects retinal ganglion cells from ocular hypertensive injury.
    Liu J; Koutalos Y; Fan J
    Exp Eye Res; 2024 Oct; 247():110061. PubMed ID: 39182597
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Sphingolipid changes in mouse brain and plasma after mild traumatic brain injury at the acute phases.
    Mondal K; Del Mar NA; Gary AA; Grambergs RC; Yousuf M; Tahia F; Stephenson B; Stephenson DJ; Chalfant CE; Reiner A; Mandal N
    Lipids Health Dis; 2024 Jun; 23(1):200. PubMed ID: 38937745
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Assaying Ceramide Synthase Activity In Vitro and in Living Cells Using Liquid Chromatography-Mass Spectrometry.
    Lim XY; Pickford R; Don AS
    Methods Mol Biol; 2016; 1376():11-22. PubMed ID: 26552671
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Common Bean Suppresses Hepatic Ceramide Metabolism in a Mouse Model of Metabolic Dysfunction-Associated Steatotic Liver Disease.
    Fitzgerald VK; Lutsiv T; McGinley JN; Neil ES; Playdon MC; Thompson HJ
    Nutrients; 2024 Sep; 16(18):. PubMed ID: 39339796
    [No Abstract]   [Full Text] [Related]  

  • 34. CerS2 haploinsufficiency inhibits β-oxidation and confers susceptibility to diet-induced steatohepatitis and insulin resistance.
    Raichur S; Wang ST; Chan PW; Li Y; Ching J; Chaurasia B; Dogra S; Öhman MK; Takeda K; Sugii S; Pewzner-Jung Y; Futerman AH; Summers SA
    Cell Metab; 2014 Oct; 20(4):687-95. PubMed ID: 25295789
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Ceramide accumulation in L6 skeletal muscle cells due to increased activity of ceramide synthase isoforms has opposing effects on insulin action to those caused by palmitate treatment.
    Frangioudakis G; Diakanastasis B; Liao BQ; Saville JT; Hoffman NJ; Mitchell TW; Schmitz-Peiffer C
    Diabetologia; 2013 Dec; 56(12):2697-701. PubMed ID: 23989724
    [TBL] [Abstract][Full Text] [Related]  

  • 36. In Human and Mouse Spino-Cerebellar Tissue, Ataxin-2 Expansion Affects Ceramide-Sphingomyelin Metabolism.
    Sen NE; Arsovic A; Meierhofer D; Brodesser S; Oberschmidt C; Canet-Pons J; Kaya ZE; Halbach MV; Gispert S; Sandhoff K; Auburger G
    Int J Mol Sci; 2019 Nov; 20(23):. PubMed ID: 31766565
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Developmentally regulated ceramide synthase 6 increases mitochondrial Ca2+ loading capacity and promotes apoptosis.
    Novgorodov SA; Chudakova DA; Wheeler BW; Bielawski J; Kindy MS; Obeid LM; Gudz TI
    J Biol Chem; 2011 Feb; 286(6):4644-58. PubMed ID: 21148554
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Sphingomyelin synthase 2 activity and liver steatosis: an effect of ceramide-mediated peroxisome proliferator-activated receptor γ2 suppression.
    Li Y; Dong J; Ding T; Kuo MS; Cao G; Jiang XC; Li Z
    Arterioscler Thromb Vasc Biol; 2013 Jul; 33(7):1513-20. PubMed ID: 23640498
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Very long chain ceramides interfere with C16-ceramide-induced channel formation: A plausible mechanism for regulating the initiation of intrinsic apoptosis.
    Stiban J; Perera M
    Biochim Biophys Acta; 2015 Feb; 1848(2):561-7. PubMed ID: 25462172
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Hepatic inflammatory cytokine production can be regulated by modulating sphingomyelinase and ceramide synthase 6.
    Kim MH; Ahn HK; Lee EJ; Kim SJ; Kim YR; Park JW; Park WJ
    Int J Mol Med; 2017 Feb; 39(2):453-462. PubMed ID: 28035360
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 16.